Sorry, you need to enable JavaScript to visit this website.

Featured Stories

Exploring the Latest Advances in Menstrual Migraine Research

For millions of people who menstruate, migraine attacks don’t always strike at random. For many, they’re more likely to occur in and around the days of the menstrual period, driven in part by the hormonal shifts of the cycle. When migraine attacks consistently occur on or around menstruation, the pattern has a name—menstrual migraine—and it’s more than just a bad headache.

Photograph of a woman in pajamas lying on a couch, holding her head and chest, thumbnail.

8 Lessons I’ve Learned as a Cancer Survivor

After a rare cancer diagnosis, Pfizer scientist Isis Kanevsky shares the lessons that ground her as she navigates treatment and survivorship.

Collage of a smiling woman with her dog and young girl in outdoor and indoor scenes

Then vs. Now: Flow Chemistry

The way medicines are made has changed significantly over time. Many of today’s drug molecules are larger and more complex than those developed decades ago and the methods for synthesis have evolved accordingly. As chemists design increasingly sophisticated molecules, they also need more precise and flexible ways to carry out the reactions that produce them.

Photograph of a scientist in a lab coat working with glassware in a laboratory thumbnail

Press Releases

Categories

Keywords

  • All Keywords

July 2026

June 2026

Resource Library

Resource Library

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits Details
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Contact Pfizer Media Relations

Media Contacts

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]